HYBRID EVENT: You can participate in person at Rome, Italy or Virtually from your home or work.
Scientific Programs coming soon..
Scientific Programs coming soon..
Important Alert:
X Please be aware of fraudulent communication claiming to collect conference fees through unauthorized means, including cloned email addresses and phone numbers. Magnus Group advises all attendees to only process payments through our official event website and report any suspicious activity to contact@magnusgroup.org
Title : Down’s syndrome (trisomy 21) and alzheimer disease: A common medical and scientific fight
London Jacqueline, Paris Diderot University, France
Alzheimer disease (AD) is a devasting problem for the aging population with less than 2% of cases are due to mutations on presenilins or Alzheimer Precursor Protein (APP). At the biochmical level, AD is characterized by senile plaques due to aggregation of amyloid peptides from t [....] » Read More
Title : Memory should be the primary endpoint in early AD
Matthias W Riepe, Ulm University, Germany
Choosing the endpoint of analysis of treatment efficacy determines the size of treatment effect. Effect size calculation of composite endpoints cannot be used for analysing treatment efficacy as it is distorted by the interaction of instrument and severity of disease Decline [....] » Read More
Title : Quality of life children with autism spectrum disorder
Zhenhuan Liu, Guangzhou University of Chinese Medicine, China
Objective: To investigate quality of life in children with autism spectrum disorder.This study aimed to evaluate the validity of existing QoLquestionnaires for use with children with ASD aged 8–12 years. Method 200 children with autism spectrum disorder (male: 118, female: [....] » Read More
Title : The vital role of care homes in supporting individuals with neurological conditions
Akankunda Veronicah, Golden Age Elderly Homes Kampala, Uganda
Care homes play a crucial role in providing specialized care and support to individuals with neurological conditions such as Alzheimer's disease, Parkinson's disease, and stroke survivors. These facilities offer a safe and structured environment, tailored to meet the uniq [....] » Read More
Title : Associative memory cells in physiology and pathology
Jin Hui Wang, University of Chinese Academy of Sciences, China
Associative memory occurs daily basis in lifespan, in which the basic units in memory traces have been found as associative memory cells that are critical for cognitive activities and emotion responses. In addition to encoding the physiological signals, these associative memory c [....] » Read More
Title : Electrophysiology and alzheimer's pathology: A scoping review on eeg correlations with CSF biomarkers
Charikleia Karastamati, University of Pavia, Italy
The increasing prevalence of Alzheimer’s Disease (AD) necessitates effective diagnostic strategies for early intervention. This presentation examines the relationship between electroencephalography (EEG) and cerebrospinal fluid (CSF) biomarkers, highlighting their combined [....] » Read More
Title : Semantic-based memory-encoding strategy in enhancing cognitive function and daily task performance for older adults with mild cognitive impairment: A pilot non-randomised
Karen P Y Liu, Western Sydney University, Hong Kong
Background and Aims: Nearly 20% of adults over 65 years old are affected by mild cognitive impairment and up to 70% of these will go on to develop a type of dementia. There is a strong need for further research into early intervention strategies to delay the impact of cognitive d [....] » Read More
Title : Validation study of the cogniscan computerized test for memory and processing speed in a Brazilian sample
Mariana Medeiros Assed, University of Sao Paulo, Brazil
Objective: To evaluate the psychometric properties of the Cogniscan screening test, a self-administered software for assessing episodic and working memory, focusing on validating its accuracy in a Brazilian clinical sample. Participants. Methods: This study involves 300 volunt [....] » Read More
Title : Effects of dementia on incident Post-COVID Conditions (PCC) in patients with SARS-COV-2 (COVID-19)
Nicholas Kendrick, Kaiser Permanente Mid Atlantic Permanente Medical Group, United States
Dementia is associated with a heightened acute response to SARS-CoV-2, but limited data exist on Post-COVID Conditions (PCC) in people with dementia (PWD). This retrospective study assessed PCC incidence in PWD compared to people without dementia (PWoD) within Kaiser Permanente M [....] » Read More
Title : Alzheimer’s Disease (AD) with preexisting hypofrontality versus frontal AD: radiologic and neuropsychological data in a case of likely dysexecutive alzheimer’s disease in a patient with schizophrenia
James S Maniscalco, Northwell Health Staten Island University Hospital, United States
Frontal Alzheimer’s disease (fAD) is an atypical AD variant which is difficult to differentiate from and frequently misdiagnosed as behavioural variant frontotemporal dementia (bvFTD). Most recent work has identified two subtypes of fAD: a behavioural subtype (bAD) associat [....] » Read More